StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Fusion Antibodies plc
LSE:FAB.L
Sector
Industries
Location
Market Cap
USD 9.81 M
Share Price
USD 0.08
Avg Daily Volume
547,776
Change (1 day)
-1.45%
Change (1 year)
126.81%
Change (YTD)
-3.70%
Fusion Antibodies plc Return on Assets (ROA) for the year ending March 31, 2021: -49.73%
Fusion Antibodies plc Return on Assets (ROA) is -49.73% for the year ending March 31, 2021, a 330.91% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.
-
Fusion Antibodies plc Return on Assets (ROA) for the year ending March 31, 2020 was -11.54%, a -43.02% change year over year.
-
Fusion Antibodies plc Return on Assets (ROA) for the year ending March 31, 2019 was -20.25%, a 108.59% change year over year.
-
Fusion Antibodies plc Return on Assets (ROA) for the year ending March 31, 2018 was -9.71%.
Competitors
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Novo Nordisk A/S
USD 68.61
NOVO-B.CO
-2.69
-3.77%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
Novartis AG
USD 120.78
NOVN.SW
-3.44
-2.77%
Abbott Laboratories
USD 132.02
ABT
-1.58
-1.18%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Thermo Fisher Scientific Inc.
USD 434.86
TMO
+4.13
0.96%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Boston Scientific Corporation
USD 103.20
BSX
-0.66
-0.64%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Vertex Pharmaceuticals Incorporated
USD 468.85
VRTX
-10.68
-2.23%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Bristol-Myers Squibb Company
USD 46.86
BMY
-1.66
-3.42%
GSK plc
USD 18.99
GSK.L
-0.75
-3.81%
Chugai Pharmaceutical Co., Ltd.
USD 46.36
4519.T
-0.52
-1.11%
CSL Limited
USD 158.31
CSL.AX
-1.36
-0.85%
Siemens Healthineers AG
USD 53.86
SHL.DE
-2.12
-3.79%
Regeneron Pharmaceuticals, Inc.
USD 567.74
REGN
+7.98
1.43%
Key Data
| Date | Return on Assets (ROA) | Revenue Per Share | Free Cash Flow Per Share | Dividend Per Share |
|---|
Competitors
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Novo Nordisk A/S
USD 68.61
NOVO-B.CO
-2.69
-3.77%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
Novartis AG
USD 120.78
NOVN.SW
-3.44
-2.77%
Abbott Laboratories
USD 132.02
ABT
-1.58
-1.18%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Thermo Fisher Scientific Inc.
USD 434.86
TMO
+4.13
0.96%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Boston Scientific Corporation
USD 103.20
BSX
-0.66
-0.64%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Vertex Pharmaceuticals Incorporated
USD 468.85
VRTX
-10.68
-2.23%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Bristol-Myers Squibb Company
USD 46.86
BMY
-1.66
-3.42%
GSK plc
USD 18.99
GSK.L
-0.75
-3.81%
Chugai Pharmaceutical Co., Ltd.
USD 46.36
4519.T
-0.52
-1.11%
CSL Limited
USD 158.31
CSL.AX
-1.36
-0.85%
Siemens Healthineers AG
USD 53.86
SHL.DE
-2.12
-3.79%
Regeneron Pharmaceuticals, Inc.
USD 567.74
REGN
+7.98
1.43%